The annual general meeting in InDex Pharmaceuticals Holding AB (publ) was held on Monday 20 April 2020 at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm, Sweden
STOCKHOLM, April 20, 2020 /PRNewswire/ -- The annual general meeting in InDex Pharmaceuticals Holding AB (publ) was held on Monday 20 April 2020 at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm, Sweden. The following resolutions, amongst others, were passed at the general meeting: Adoption of the income statements and balance sheets, disposal of profits, and resolution regarding discharge of liability The annual general meeting resolved, in accordance with the board of director’s proposal, that no dividend will be paid for the financial year of 2019. The annual general meeting resolved to grant discharge of liability for the members of the board of directors and the managing director for the financial year of 2019. Board of directors, auditors, and fees The annual general meeting resolved, in accordance with the nomination committee’s proposal, that the fees for the board of directors for the time until the next annual general meeting shall amount to SEK 400,000 for the chairman of the board of directors and SEK 200,000 for each ordinary member of the board of directors. Fees to the company’s auditor for the same period shall be paid in accordance with approved invoices. Resolution regarding directed issue of warrants (incentive program) The nomination committee’s proposal regarding issue of warrants (incentive program) within an incentive program for members of the board of directors was not approved, as the resolution did not acquire the required majority of votes. InDex Pharmaceuticals in brief InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Redeye AB with email address certifiedadviser@redeye.se och phone number +46-8-121-576-90 is the company’s Certified Adviser. For more information, please visit www.indexpharma.com. Publication For more information: This information was brought to you by Cision http://news.cision.com The following files are available for download:
SOURCE Index Pharmaceuticals | ||||
Company Codes: ISIN:SE0008966295, Stockholm:INDEX |